Skip to content

Evera MRI Clinical Study

Evera MRI Clinical Study - Evera MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53163
Enrollment
45
Registered
2014-07-18
Start date
2014-08-11
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arrhythmia

Interventions

Two out of three subjects will obtain a MRI scan 9-12 weeks after the implantation.
Evera MRI
MRI scan

Sponsors

Medtronic Trading NL BV
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patient is indicated for the first time for an ICD implantation Patient is willing and able to undergo elective MRI scanning

Exclusion criteria

Exclusion criteria: Patient has contraindication for an ICD. Patient has contraindication for an elective MRI scan.

Design outcomes

Primary

MeasureTime frame
Primary Objectives: Safety: To demonstrate an acceptable MRI-related event-free rate. Efficacy: To demonstrate that the proportion of patients whose ventricular pacing capture threshold increases significantly one month post-MRI/waiting period is similar between the MRI group and the control group.

Secondary

MeasureTime frame
Secondary Objectives: - To demonstrate an acceptable system-related complication rate. - To demonstrate the system integrity of the high-voltage ICD component after MRI exposure. - To demonstrate that the proportion of patients whose atrial pacing capture threshold increases significantly one month post-MRI/waiting period is similar between the MRI group and the control group.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)